Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastrointest Endosc. Dec 16, 2012; 4(12): 561-564
Published online Dec 16, 2012. doi: 10.4253/wjge.v4.i12.561
Table 1 Clinical characteristics of study participants at year 0
Number of ACF
P value
Total0-3> 3
No. of subjects894148
Age (yr)63.4 ± 11.162.6 ± 12.964.1 ± 9.50.52
Gender (male:female)61:28:0028:14:0033:15:00
Waist Circumference (cm)85.9 ± 11.584.7 ± 8.186.7 ± 13.60.57
BMI (kg/m2)23.2 ± 3.122.6 ± 2.323.8 ± 3.60.09
Total cholesterol (mg/dL)210.7 ± 34.9208.7 ± 32.6212.2 ± 36.90.69
Triglyceride (mg/dL)146.2 ± 77.1125.9 ± 64.1161.5 ± 83.20.06
Hemoglobin A1c (%)5.9 ± 1.35.6 ± 1.26.2 ± 1.40.13
TFA (cm2)198.9 ± 95.2177.0 ± 55.6215.5 ± 115.20.19
VFA (cm2)90.4 ± 53.575.6 ± 41.1101.6 ± 59.70.11
SFA (cm2)108.5 ± 58.1101.4 ± 45.7113.9 ± 66.40.49
Table 2 Endoscopic results of adenoma at year 0 and year 1
No. of aberrant crypt foci at year 00-3> 30-3 vs > 3
No. of subjects4148
No. of adenoma at year 01.4 ± 1.21.6 ± 1.80.71
Maximum size of adenoma at year 06.0 ± 4.66.3 ± 7.20.81
No. of adenoma at year 11.0 ± 1.01.5 ± 1.40.08
Maximum size of adenoma at year 13.5 ± 3.55.5 ± 5.80.031